Advanced molecular and immunological diagnostic methods to detect SARS-CoV-2 infection

JC Rotondo, F Martini, M Maritati, E Caselli… - Microorganisms, 2022 - mdpi.com
Simple Summary COVID-19 emerged in late 2019 in China and rapidly spread across the
globe. After 2 years, numerous advances have been made. First of all, the preventive …

A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera

C Seephetdee, K Bhukhai, N Buasri… - Antiviral research, 2022 - Elsevier
Next-generation COVID-19 vaccines are critical due to the ongoing evolution of SARS-CoV-
2 virus and rapid waning duration of the neutralizing antibody response against current …

Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study

Q Hua, H Zhang, P Yao, N Xu, Y Sun, H Lu… - Frontiers in …, 2022 - frontiersin.org
Background Owing to the coronavirus disease 2019 (COVID-19) pandemic and the
emergency use of different types of COVID-19 vaccines, there is an urgent need to consider …

Humoral response to BNT162b2 vaccine against SARS-CoV-2 variants decays after six months

TJ Lopera, M Chvatal-Medina… - Frontiers in …, 2022 - frontiersin.org
SARS-CoV-2 vaccines have shown very high effectiveness in real-world scenarios.
However, there is compelling evidence for a fast-paced waning of immunity. The increasing …

Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population

F Martel, J Cuervo-Rojas, J Ángel, B Ariza… - Frontiers in …, 2023 - frontiersin.org
The SARS CoV-2 antibody and CD4+ T cell responses induced by natural infection and/or
vaccination decline over time and cross-recognize other viral variants at different levels …

Description of a One-Year Succession of Variants of Interest and Concern of SARS-CoV-2 in Venezuela

RC Jaspe, CL Loureiro, Y Sulbaran, ZC Moros… - Viruses, 2022 - mdpi.com
Some of the lineages of SARS-CoV-2, the new coronavirus responsible for COVID-19,
exhibit higher transmissibility or partial resistance to antibody-mediated neutralization and …

Assessment of SARS-CoV-2 Mu variant emergence and spread in Colombia

J Hernandez-Ortiz, A Cardona, K Ciuoderis… - JAMA Network …, 2022 - jamanetwork.com
Assessment of SARS-CoV-2 Mu Variant Emergence and Spread in Colombia | Global Health |
JAMA Network Open | JAMA Network [Skip to Navigation] Our website uses cookies to enhance …

Neutralization of Different Variants of SARS-CoV-2 by a F (Ab′) 2 Preparation from Sera of Horses Immunized with the Viral Receptor Binding Domain

M Rodriguez-Nuñez, MV Cepeda, C Bello, MA Lopez… - Antibodies, 2023 - mdpi.com
The Receptor Binding Domain (RBD) of SARS-CoV-2, the virus responsible for the COVID-
19 pandemic, is the functional region of the viral Spike protein (S), which is involved in cell …

Population pharmacokinetics and pharmacodynamics of HFB30132A, a monoclonal antibody against SARS-CoV-2, in healthy Chinese and US subjects

Y Chen, S Li, W Hedrich, X Wu, S Li, C Qiu, K Lin… - International Journal of …, 2025 - Elsevier
Abstract Development of neutralizing monoclonal antibody (nAb) is a strategy for treatment
of infections caused by SARS-CoV-2. This study evaluated the pharmacokinetics (PK) and …

Potential Antiviral Activity of Lactiplantibacillus plantarum KAU007 against Influenza Virus H1N1

IA Rather, MR Kamli, JSM Sabir, BA Paray - Vaccines, 2022 - mdpi.com
The development of antiviral resistance has exacerbated a growing threat to public health.
As a result, there is increasing demand for unconventional antivirals that can effectively …